Early research (Phase 1)UnknownNCT05554666What this trial is testingASKG315 in Patients With Advanced Solid Tumors.Who this might be right forAdvanced Solid Tumors AskGene Pharma, Inc. 56
Not applicableStudy completedNCT06073951What this trial is testingEvaluation of a Couple-Based Physical Activity InterventionWho this might be right forHematopoietic and Lymphoid System NeoplasmMalignant Solid Neoplasm Mayo Clinic 96
Testing effectiveness (Phase 2)Study completedNCT05795595What this trial is testingA Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid TumorsWho this might be right forClear Cell Renal Cell CarcinomaCervical CarcinomaEsophageal Carcinoma+2 more CRISPR Therapeutics AG 19
Testing effectiveness (Phase 2)Looking for participantsNCT06941272What this trial is testingPatritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)Who this might be right forMalignant Neoplasm Merck Sharp & Dohme LLC 50
Early research (Phase 1)Active Not RecruitingNCT03168737What this trial is testing18F-Fluoroazomycin Arabinoside PET-CT in Diagnosing Solid Tumors in PatientsWho this might be right forMalignant Breast NeoplasmMalignant Colorectal NeoplasmMalignant Pancreatic Neoplasm+1 more M.D. Anderson Cancer Center 25
Early research (Phase 1)Study completedNCT00003107What this trial is testingInterleukin-12 in Treating Patients With Hematologic Cancers or Solid TumorsWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+8 more Indiana University
Early research (Phase 1)Looking for participantsNCT06299839What this trial is testingPAS-004 in Patients With Advanced Solid TumorsWho this might be right forRAS MutationNF1 MutationRAF Mutation+1 more Pasithea Therapeutics Corp. 48
Testing effectiveness (Phase 2)UnknownNCT06082557What this trial is testingObserve and Evaluate the Safety and Efficacy of T60c Injection for Treatment of Advanced Solid Tumor PatientsWho this might be right forMalignant Solid Tumors Cancer Institute and Hospital, Chinese Academy of Medical Sciences 62
Not applicableStudy completedNCT05766332What this trial is testingEvaluating Clinical Evaluation Tools for Predicting Risk of Complications After Hematopoietic Stem Cell TransplantWho this might be right forHematopoietic and Lymphoid System NeoplasmMalignant Solid Neoplasm Mayo Clinic 137
Testing effectiveness (Phase 2)Study completedNCT02272998What this trial is testingPonatinib for Patients Whose Advanced Solid Tumor Cancer Has Activating Mutations Involving the Following Genes: FGFR1, FGFR2, FGFR3, FGFR4, RET, KIT.Who this might be right forMalignant Neoplasm Sameek Roychowdhury 22
Early research (Phase 1)Looking for participantsNCT07824934What this trial is testingHEC-921 Injection as Monotherapy and in Combination With Antineoplastic Therapies in Patients With Advanced Malignant Solid TumorsWho this might be right forAdvanced Malignant Solid Tumors Sunshine Lake Pharma Co., Ltd. 110
Not applicableLooking for participantsNCT01772771What this trial is testingMolecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy ProgramWho this might be right forGliomaHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm+2 more M.D. Anderson Cancer Center 12,000
Early research (Phase 1)Study completedNCT00020267What this trial is testingVaccine Therapy in Treating Patients With Metastatic CancerWho this might be right forLung CancerAdult Soft Tissue SarcomaColorectal Cancer+8 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Active Not RecruitingNCT04225117What this trial is testingEvaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)Who this might be right forLocally Advanced or Metastatic Malignant Solid Tumors Astellas Pharma Global Development, Inc. 329
Not applicableActive Not RecruitingNCT04409236What this trial is testingQuit2Heal Smartphone App in Helping Cancer Patients Quit SmokingWho this might be right forHematopoietic and Lymphoid System NeoplasmMalignant Solid Neoplasm Fred Hutchinson Cancer Center 427
Testing effectiveness (Phase 2)Ended earlyNCT06630325What this trial is testingA Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic CancerWho this might be right forAdvanced Breast CarcinomaAdvanced Malignant Solid NeoplasmAdvanced Ovarian Carcinoma+11 more OHSU Knight Cancer Institute 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT03213652What this trial is testingEnsartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmMalignant Solid NeoplasmRecurrent Ependymoma+30 more National Cancer Institute (NCI) 13
Early research (Phase 1)Looking for participantsNCT06728189What this trial is testingA Clinical Research About CD70-targeted CAR-NKT Cells Therapy in Subjects with Advanced Malignant Solid TumorsWho this might be right forAdvanced Malignant Solid Tumors Peking University Cancer Hospital & Institute 13
Testing effectiveness (Phase 2)Study completedNCT03220035What this trial is testingVemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmAnn Arbor Stage III Childhood Non-Hodgkin LymphomaAnn Arbor Stage IV Childhood Non-Hodgkin Lymphoma+20 more National Cancer Institute (NCI) 4
Early research (Phase 1)Looking for participantsNCT05372640What this trial is testingTesting the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid TumorsWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast Carcinoma+5 more National Cancer Institute (NCI) 45